The aryl hydrocarbon receptor (AhR) is targeted by ubiquitination for degradation by the proteasome shortly after its activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). In silico screening identified p-anilinoaniline (pAA) as a putative inhibitor of an E2 ligase that partners with an E3 ligase implicated in AhR ubiquitination. We investigated if pAA could modify AhRdependent activation of its target gene CYP1A1. pAA (1-200 μM) alone did not affect AhR content, or stimulate CYP1A1 mRNA accumulation in human mammary epithelial MCF10A
Introduction
In many cell types the AhR undergoes proteolysis following the binding of agonist. For example, TCDD binding reduces AhR half-life from 28 h to ~3 h in murine hepatoma 1c1c7 cells (Ma and Baldwin, 2002) . AhR degradation occurs as a consequence of its becoming polyubiquitinated, which targets it to the proteasome for proteolysis (Pollenz, 2002) . Polyubiquitination is mediated by the sequential actions of three interacting, but functionally distinct proteins: an E1 ubiquitin activating enzyme, the E2 ubiquitin conjugating enzymes and the E3 ubiquitin ligases (Pickart, 2001) . There are about 50 known E2s and possibly hundreds of E3
proteins. The E3 proteins are responsible for substrate discrimination and the specificity of ubiquitination. A single E2 is able to associate with different E3s, and an individual E3 may associate with more than one E2 (Hershko and Ciechanover, 1998) . Although the identities of the E2 and E3 proteins involved in ligand-induced AhR ubiquitination are not well characterized, some studies have implicated a role for the E3 ligase CHIP (Lees et al., 2003; Morales and Perdew, 2007) . CHIP contains a U-box domain, and interacts with hsp90 and hsc70 client proteins targeting them for degradation by the ubiquitin proteasome pathway (Connell et al., 2001 ). One of the E2 conjugating enzymes that partners with CHIP is UbcH5a ).
p-Anilinoaniline (pAA; also known as p-aminodiphenylamine, N-phenyl-1,4-benzenediamine) is an aromatic amine that is used in hair coloring products. It is also a major metabolite of the azo dye metanil yellow (Srivastava et al., 1982) . The latter is extensively used in the textile, paper, lacquer/stain industries (Mittal et al., 2008) , and in India as a food-coloring agent (Khanna et al., 1985) . As the consequence of in silico screening, Banerjee (2006) identified This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on February 16, 2012 as DOI: 10.1124 at ASPET Journals on April 6, 2017 dmd.aspetjournals.org Downloaded from pAA (identified as 05RB in the paper) as a putative inhibitor of UbcH5a, an E2 conjugating enzyme that partners with the E3 ligase CHIP.
We initiated the current study with the intent of assessing pAA as a possible inhibitor of TCDD-induced AhR ubiquitination in the normal human mammary epithelial cell line MCF10A.
We previously reported that TCDD induced AhR degradation and the expression of multiple AhR-responsive phase I and II metabolism-related genes (i.e., CYP1A1, CYP1A2, CYP1B1 and NQO1) in MCF10A cultures (Reiners et al., 1997; Gou et al., 2004; Joiakim et al., 2004) .
Unfortunately, MCF10A cultures ultimately proved to be an inappropriate model for the testing of our hypothesis since the line did not express UbcH5a. However, we found that pAA mediated a very reproducible time-dependent enhancement of CYP1A1 induction by TCDD that paralleled pAA-induced cell cycle arrest and release. Specifically, our data indicate that TCDD-induced AhR occupancy of the CYP1A1 promoter and CYP1A1 transcriptional activation in MCF10A cells are maximal in late G 1 and early/mid S phase cells.
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Viability was scored as the ability to exclude trypan blue.
Cell Cycle Analyses. The procedure used for the determination of cell cycle phase by fluorescence activated cell sorting has been described in detail (Reiners et al., 1999) .
Western Blot Analyses. The conditions used for the preparation of cell extracts, separation of proteins on SDS-polyacrylamide gels, and transfer of separated proteins onto nitrocellulose membranes have been described in detail (Guo et al., 2001) . Nonspecific antibody binding to transferred proteins was blocked by pre-incubating membranes in PBS-T (20 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween-20) supplemented with 5% non-fat dry milk proteins. After washing with PBS-T, membranes were incubated with the appropriate horseradish peroxidase secondary antibody for 1.5 h at room temperature. Antibody detection was performed with an enhanced chemiluminescence reaction kit (Amersham Pharmacia Biotech, Piscataway, NJ), and recorded on x-ray film.
RNA Preparation and Northern Blot Analyses.
The conditions used for RNA isolation, resolution of RNAs on agarose/formaldehyde gels, and transfer to nitrocellulose membranes have been described by Reiners et al. (1997) . The probes and hybridization conditions used for the detection of human 7S, CYP1A1, and CYP1A2 RNAs have been described in detail (Reiners et al., 1997; Joiakim et al., 2004) . Northern blot data were normalized by calculating CYP1A1 or CYP1A2 mRNA to 7S RNA signal strength ratios.
Real Time RT-PCR of CYP1A1 hnRNA. Total RNA was isolated from MCF10A cultures using the RNAquous-4PCR kit according to manufacturer's specifications. RNA was treated with DNase 1 according to the instructions provided by kit's manufacturer in order to remove trace amounts of DNA, and was quantified using a NanoDrop Spectrophotometer (NanoDrop This article has not been copyedited and formatted. The final version may differ from this version. AhR-DNA interactions were monitored using forward (5'-ACCCGCCACCCTTCGACAGTTC-3') and reverse (5'-TGCCCAGGCGTTGCGTGAGAAG-3') primers to amplify a region from -980 to -1125 of the CYP1A1 promoter (Matthews et al., 2005) . This region contains two functional XREs and yields a PCR product of 146 bp. The PCR Electrophoretic Mobility Shift Assay. The conditions used for TCDD-mediated AhR transformation in rat liver extracts, EMSA, and the sequence of the double stranded radiolabeled oligonucleotide containing a consensus XRE, have been published (Joiakim, et al., 2004) .
Image and statistical Analyses. EMSA, western and northern blot films were scanned at 800-1000 dpi and saved as tif images. Band intensities in the images were quantified with ImageJ software. Data were analyzed by one-way ANOVA followed by Tukey's multiple comparison test, using GraphPad Prism Version 4.02 for Windows (GraphPad Software, San
Diego, CA). P < 0.05 was considered statistically significant. CYP1A2, like CYP1A1, is transcriptionally activated by TCDD in MCF10A cultures (Joiakim et al., 2004) . pAA alone had no effect on CYP1A2 mRNA content in MCF10A cultures (Joiakim, unpublished data) . However, pretreatment with 25 μM pAA enhanced dioxin-induced CYP1A2 mRNA contents by ~2-fold ( The accumulation of CYP1A1 mRNA following TCDD treatment could reflect either enhanced CYP1A1 transcription, or a stabilization of CYP1A1 mRNA. In order to examine the former, we made cDNA to total RNA and used PCR to amplify hnRNA sequences that encompassed the exon 1 -intron 1 boundary of CYP1A1 ( Fig. 2A) . Analysis of hnRNA has been used as a surrogate assay for monitoring the transcriptional activation of CYP1A1 (Elferink and Reiners, 1996) . Exposure to either DMSO or 25 mM pAA did not alter CYP1A1 hnRNA content 12 over a 8 h time period; whereas, TCDD treatment resulted in an ~20-fold increase (Fig. 2B ).
Pretreatment with 25 mM pAA, followed by TCDD addition, increased CYP1A1 hnRNA content ~2-fold above what accumulated following 6 h of just TCDD exposure (Fig. 2C ).
In order to assess the effects of pAA on CYP1A1 mRNA stability we pretreated cultures with TCDD ± pAA for 8 h before adding 5 μg/ml actinomycin D (ActD), a concentration that completely inhibits CYP1A1 transcription (Chen et al., 1995; Ciolino et al., 1999) . Total RNA was subsequently collected at 2 h intervals for measurement of CYP1A1 mRNA (Fig. 3A) .
Decreases in mRNA content following ActD treatment became very apparent with passing time. A strong inhibition of TCDD-induced AhR loss was observed in cultures cotreated with 100 μM pAA (Fig. 4A, p<0 .05 for n = 4 independent experiments), whereas, 10 μM pAA was without effect (Fig. 4A ). Kinetic analyses of intermediate concentrations suggested that 50 μM pAA partially blocked TCDD-induced AhR degradation (Fig. 4B, p<0 .05 for n = 3 independent experiments). Although 25 μM pAA appeared to exhibit a small protective trend, the AhR contents of TCDD and TCDD + pAA treated cultures were not significantly different (Fig. 4C ).
Although the effect of pretreatment with 25-50 μM pAA on AhR content was small, we wondered if it might be sufficient to mediate the enhanced accumulation of CYP1A1 mRNA after TCDD exposure. As an approach to the issue we intended to knock down the putative E2
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Hence, it seemed unlikely that the effects of pAA on AhR content and CYP1A1 induction were related to the pAA effects on the E2 UbcH5a.
AhR agonist and antagonist activities of pAA. The ability of pAA to suppress both TCDD-induced AhR proteolysis and CYP1A1 transcription at 100 μM is consistent with it functioning as an AhR antagonist. We used an electrophoretic mobility shift assay (EMSA) to examine this issue. Incubation of rat liver cytosol with 10 nM TCDD effectively transformed the AhR into a species capable of binding to a radiolabeled oligo containing a xenobiotic-responsive element ( pAA addition (Fig. 6A) . Notably, the onset of G 1 cells transitioning into S phase, and the period of S phase cell accumulation, roughly correlate with when pAA cotreatment enhanced TCDD activation of CYP1A1 (compare Fig. 1C and 6A ). This temporal relationship is significant since we previously reported that CYP1A1 induction may be cell cycle regulated (Santini et al., 2001 ).
In order to examine the relationship between AhR function and cell cycle phase in detail, we quantified TCDD-mediated transcriptional activation of CYP1A1 at different times after pAA treatment. Prior to initiating this study we determined if TCDD had any effects on MCF10A cell cycle progression. A concentration of TCDD sufficient to activate CYP1A1 transcription neither altered cell cycle phase distributions over a 24 h treatment period when used singularly (Supplemental Figure 1) , nor altered the development and resolution of pAA-induced G 1 and S phase arrest. The latter studies were performed in two ways. In one protocol TCDD was added 1.5 h after pAA addition, and cell cycle analyses were performed throughout a 24 h period (Supplemental Figure 1) . In the second protocol we treated cultures with TCDD at various times after pAA addition, and harvested cultures 3 h after dioxin addition (Fig. 6B ). This latter protocol facilitated very detailed analyses of TCDD effects on specific phases of the cell cycle. Overall, TCDD had no detectable effects on MCF10A cell cycle progression.
Cultures treated similarly to those in Figure 6B were analyzed for CYP1A1 mRNA ( Fig.   6C ) and hnRNA (Fig. 6D) following the TCDD addition. In these studies we harvested cultures within 3 h of TCDD addition in order to restrict the effects of dioxin to defined stages of the cell cycle. The length of time elapsed between pAA and dioxin additions influenced the extent to which CYP1A1 mRNA and hnRNA accumulated. CYP1A1 mRNA contents were maximally increased when dioxin was added to cultures in late G 1 or transitioning from G 1 to S (i.e., time of harvest = 13 h), and in early -middle S phase (i.e., time of harvest = 15 h; Figure 6C ). Late S This article has not been copyedited and formatted. The final version may differ from this version. CYP2S1 is transcriptionally activated by TCDD through an AhR-dependent mechanism (Saarikoski et al., 2005; Riveria et al., 2007) . Thomas et al. (2007) previously reported that CYP2S1 mRNA accumulates in MCF10A cultures following the addition of dioxin. In asynchronous MCF10A cultures we observed no accumulation of CYP2S1 mRNA within 3 h of TCDD addition (Fig.7A) . However, this time period was sufficient for CYP2S1 mRNA accumulation if the cultures were pretreated with pAA (Fig. 7A ). Like CYP1A1, optimal accumulations of CYP2S1 mRNA occurred when cultures were treated with TCDD in late G 1 , during the G 1 /S transition and early/mid S phase (Compare Figs. 7A and B, hours 5-12 after pAA addition).
pAA effects on CYP1A1 induction in HepG2 cultures. We examined the effects of pAA in HepG2 cells in order to determine if its effects on CYP1A1 induction were cell type specific.
pAA suppressed the proliferation of HepG2 in a concentration-dependent fashion (Fig. 8A ) that mirrored the effects observed in MCF10A cells (Elliott and Reiners, 2008 The cytostatic effects of 25 μM pAA reflected the induction of an early G 1 and S phage arrest, with arrested G 1 phase cells transitioning into S phase 8-16 h after pAA addition (Fig. 8B) .
Unlike MCF10A cultures, pAA-treated cultures remained arrested in S phase 28 h after treatment (Fig. 8B) . Treatment of asynchronous HepG2 cultures with TCDD increased CYP1A1 mRNA content 11-to 19-fold within 3 h of dioxin addition (Fig. 8C) . Pretreatment with pAA increased TCDD-induced CYP1A1 mRNA accumulation above that achieved with just TCDD (Fig. 8C) .
However, unlike what we observed with MCF10A cultures, the effects of pAA pretreatment on TCDD-mediated CYP1A1 induction were not cell cycle dependent. Instead, pAA enhanced CYP1A1 mRNA accumulation irrespective of the cell cycle stage at which TCDD was added (Fig. 8C ).
Although CYP2S1 mRNA was detected in the non-treated asynchronous HepG2 cultures reported in Fig. 8 , we observed no induction of CYP2S1 in these cultures following a 3 h treatment with TCDD, or combined pAA and TCDD cotreatment (unpublished data).
This article has not been copyedited and formatted. The final version may differ from this version. A second pAA-related activity became apparent at concentrations ranging from 10 and 50
μM. Specifically, treatment of MCF10A cultures with these concentrations prior to TCDD addition elevated CYP1A1 mRNA contents above that occurring with dioxin alone. We In addition to CYP1A1, the ligand-activated AhR regulates the transcription of numerous genes having XREs in their promoters (Sun et al., 2004 ). In the current study we observed that the induction of CYP2S1 by TCDD In MCF10A cultures was also cell cycle-dependent. Similarly, Jiao et al. (2007) reported maximal accumulations of CYP1A2 and CYP1B1 mRNA in S phase MCF-7 cultures following benzo[a]pyrene treatment. Hence, agonist induction of multiple AhRresponsive genes appears to be cell cycle-dependent in MCF10A and MCF-7 cultures. However,
given that similar effects were not observed in HepG2 cultures, it appears that the cell cycle dependency of CYP1A1 induction may be cell type specific. We do not know the basis for this cell context dependency, but it also extends to other aspects of CYP1A1 regulation in the three cell lines. Whereas pretreatment of MCF10A (Guo et al., 2001 ) and MCF-7 (Moore et al., 1993) cultures with 12-O-tetradecanoylphorbol-13-acetate initially suppresses TCDD-mediated induction of CYP1A1, a similar pretreatment enhances CYP1A1 transcription in HepG2 cultures (Chen and Tukey, 1996; Morgan et al., 1998) .
This article has not been copyedited and formatted. The final version may differ from this version. Two timekeepers appear to regulate TCDD-mediated transcriptional activation of CYP1A1.
The first entails the cell cycle and the second circadian rhythms. Regarding the latter, TCDDmediated induction of CYP1A1 in the liver and mammary glands of mice is 23-40 fold greater at night than during daytime (Qu et al., 2007; Qu et al., 2010) . This diurnal rhythm in CYP1A1 responsiveness to TCDD is inversely related to the expression of the protein Period 1 (Metz et al., 2006 : Qu et al., 2010 , a key protein regulator of the circadian clock (Reppert and Weaver, 2002) . The occurrence of this cyclical rhythm for CYP1A1 responsiveness in a quiescent tissue such as the liver emphasizes the independence of the two timekeepers in some situations.
However, several studies have demonstrated that circadian rhythms gate the expression/activation of cell cycle related genes in proliferating tissues (Matsuo et al., 2003; Yang et al., 2009 ). For example, in normal human oral mucosa the maximum accumulation of Period 1 occurs in G 1 prior to the expression of cyclin E, and the onset of S phase occurs after appreciable Period 1 loss (Bjarnason et al., 2001) . A similar pattern is also observed in human skin (Bjarnason et al., 2001) . Although speculative, it is conceivable that cell cycle and circadian rhythm dependent regulation of TCDD-induced CYP1A1 transcription maybe linked in vivo, in some proliferating tissues.
Protocols that facilitate manipulation of cell density indicate that cell-cell contact also influences AhR activation and the transcription of several AhR-responsive genes (Cho et al., 2004; Ikuta et al., 2004; and references within) . Specifically, the expression of both CYP1A1 and CYP1B1 in cultured adherent cells, in the absence of any exogenous AhR ligand, is inversely related to cell density (Cho et al., 2004; Ikuta et al., 2004 ). In some instances the level of agonists (Cho et al., 2004; Ikuta et al., 2004; and references within) . Interestingly, studies with cultured keratinocytes (Ikuta et al., 2004) and fibroblasts (Cho et al., 2004) indicate that cell contact/density-mediated regulation of the AhR and CYP1A1/CYP1B1 is cell cycle phase independent.
Agonist activation of the AhR can have diverse effects on the cell cycle. For example, contact inhibited, quiescent rat liver epithelial WB-F344 cultures reenter the cell cycle and proliferate following exposure to TCDD and several polychlorinated biphenyl and polycyclic aromatic hydrocarbon AhR agonists (Chramostová et al., 2004; Vodrácek et al., 2005) .
Conversely, TCDD induces a profound G 1 or S phase arrest in a variety of cultured cell types (reviewed by Marlowe and Puga, 2005; Puga et al., 2009; Barhoover et al., 2010) . In many cases this arrest has been shown to be AhR dependent (Marlowe and Puga, 2005) . The MCF10A cells used in the current study appear to represent a third case. Specifically, concentrations of dioxin sufficient to induce CYP1A1 transcription had no notable effect on MCF10A cell cycle progression. Collectively, these data indicate that dioxin effects on the cell cycle are cell context dependent. However, it should be noted that even for a specific cell type, additional factors radically influence dioxin's effects on the cell cycle. For example, whereas dioxin suppresses compensatory liver regeneration induced by partial hepatectomy, it enhances hepatocyte proliferation induced by the hepatomitogen 1,4-bis[2-(3,5-dichloropyridyloxyl] benzene (Mitchell et al, 2010) .
In summary, the current study demonstrates that dioxin-mediated transcriptional activation of CYP1A1 is optimal in late G 1 and early/mid S phase MCF10A cells. Similar observations have been made in other cell lines (Santani et al., 2001; Jiao et al., 2007) . These findings raise the broader issue of whether other genes associated with metabolic transformation This article has not been copyedited and formatted. The final version may differ from this version. 
